Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate-specific membrane antigen (PSMA) is a cell membrane glycoprotein that is selectively expressed in prostate cells, with expression levels increasing dramatically in prostatic adenocarcinoma. PSMA-based radioligand therapy (RLT) has emerged as a viable therapeutic modality for the treatment o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cureus
Autors principals: Sun, Michael, Niaz, Muhammad O, Nelson, Adlai, Skafida, Myrto, Niaz, Muhammad J
Format: Artigo
Idioma:Inglês
Publicat: Cureus 2020
Matèries:
Internal Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392183/
https://ncbi.nlm.nih.gov/pubmed/32760622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.8921
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars